There are studies that reported DIABLO as overexpressed in GC, CRC, and ovarian cancer and as downregulated in PCa, lung, and soft tissue cancers, as well as in BC tissues, with its expression decreasing with BC progression [47]. Here, DIABLO is linked to short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome.